Sort   by:  
 Page size 
UnknownOutcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
Not available
S-EPMC8847487 | biostudies-literature
UnknownSulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates.
Not available
S-EPMC10358168 | biostudies-literature
UnknownContribution of mechanoreceptors to spinal cord injury-induced mechanical allodynia.
Not available
S-EPMC11090032 | biostudies-literature
UnknownEpigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward.
Not available
S-EPMC3805867 | biostudies-literature
UnknownA comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Not available
S-EPMC4222644 | biostudies-literature
UnknownDNA methylation temporal profiling following peripheral versus central nervous system axotomy.
Not available
S-EPMC4411011 | biostudies-literature
UnknownSafety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies.
Not available
S-EPMC4735234 | biostudies-literature
UnknownHuman Pulmonary Neuroendocrine Cells Respond to House Dust Mite Extract With PAR-1 Dependent Release of CGRP.
Not available
S-EPMC11969319 | biostudies-literature
UnknownIn vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program.
Not available
S-EPMC10232259 | biostudies-literature
UnknownNecrotizing Fasciitis Within 72 hours After Presentation with Skin and Skin Structure Infection.
Not available
S-EPMC7390563 | biostudies-literature
Sort   by:  
 Page size